E3 PreliminaryPreliminaryPEM unclearCross-SectionalPeer-reviewedMachine draft
In chronic fatigue syndrome, the decreased levels of omega-3 poly-unsaturated fatty acids are related to lowered serum zinc and defects in T cell activation.
Maes, Michael, Mihaylova, Ivana, Leunis, Jean-Claude · Neuro endocrinology letters · 2005
Quick Summary
This study found that people with ME/CFS have lower levels of omega-3 fatty acids (healthy fats found in fish) and higher levels of other types of fats compared to healthy people. These imbalances were linked to lower zinc levels and problems with immune cells called T cells, which help fight infection. The researchers suggest that omega-3 supplements might help ME/CFS patients.
Why It Matters
This study provides mechanistic insight into a potential nutritional and immune abnormality in ME/CFS, suggesting a testable intervention (omega-3 supplementation) that is safe and accessible. Understanding fatty acid metabolism and its link to T cell dysfunction may help explain both immune dysfunction and symptom severity in ME/CFS.
Observed Findings
- CFS patients had significantly lower EPA/arachidonic acid ratio and total omega-3/omega-6 ratio compared to controls.
- Omega-3/omega-6 ratio was significantly negatively correlated with illness severity and symptoms (pain, fatigue, memory problems).
- Omega-3/omega-6 ratio was significantly positively correlated with serum zinc levels.
- Omega-3/omega-6 ratio correlated positively with T cell activation markers (CD69 expression on CD3+, CD4+, and CD8+ T cells).
Inferred Conclusions
- Decreased omega-3 PUFA availability is involved in the pathophysiology of ME/CFS.
- Omega-3 deficiency is associated with both lowered zinc levels and defective T cell activation in CFS.
- CFS patients may benefit from omega-3 PUFA supplementation (EPA and DHA).
Remaining Questions
- Does omega-3 supplementation actually improve symptoms or immune function in ME/CFS patients?
- Is the fatty acid imbalance primary (contributing to disease) or secondary (a consequence of illness)?
- What mechanisms link omega-3 deficiency to zinc depletion and T cell dysfunction in ME/CFS?
What This Study Does Not Prove
This study does not prove that omega-3 deficiency *causes* ME/CFS or that supplementation will treat it—only that an association exists. The small sample size and cross-sectional design cannot establish causality or rule out that illness severity changes fatty acid metabolism rather than the reverse. The study does not test whether omega-3 supplementation improves outcomes.
Tags
Symptom:Cognitive DysfunctionPainFatigue
Biomarker:MetabolomicsBlood Biomarker
Method Flag:PEM Not DefinedSmall SampleExploratory Only
Metadata
- PMID
- 16380690
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →